The global pharmaceutical packaging market size is estimated to be USD 132.0 billion in 2023 and is projected to reach USD 269.9 billion at a CAGR of 15.4% during the forecast period. The reports 2025 research report offers an analytical view of the industry by studying different factors like pharmaceutical packaging market growth, consumption volume, Market Size, Revenue, Market Share, Market Trends, and pharmaceutical packaging industry cost structures during the forecast period from 2025 to 2028. The surge in urbanization, evolving lifestyles, increased disposable income, a growing preference for sustainable packaging, and global awareness of diseases are driving the expansion of the pharmaceutical packaging market. However, challenges include the elevated costs of raw materials used in manufacturing packaging products. Financial constraints, lack of information, outdated equipment, lack of proper staff, and awareness of proper healthcare practices are the major challenges that limit access to healthcare services. Opportunities arise from the rising demand for sustainable packaging, as it reduces waste and minimizes the impact of pharmaceutical products on the environment.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=890
“Plastic bottles is largest growing segment on the basis of type, in terms of value, during the forecast period.”
The demand for plastic bottles in the pharmaceutical packaging market is due to several factors including improved barrier properties, low water absorption, high impact strength, transparency, high dimensional stability, resistance to strain, heat, and flame resistance. Plastic bottles offer pharmaceutical companies convenience in transportation due to their ease of handling and reduced risk of breakage compared to glass bottles. Their durability minimizes the potential for product loss and safety concerns associated with breakages, making them a preferred choice in the pharmaceutical plastic bottle market. The use of plastic bottles aligns with stringent government regulations, underscoring their suitability for pharmaceutical packaging.
“Primary packaging form is largest growing segment on the basis of packaging type, in terms of value, during the forecast period.”
Various factors contribute to the increasing demand for the primary packaging segment in the pharmaceutical packaging market. These include the increasing prevalence of diseases, advancements in biotechnology and novel therapies, innovations in materials, rising healthcare expenditures, diversification of product portfolios, adherence to regulatory standards and quality assurance, as well as consumer preferences. The protection of pharmaceutical products from external factors such as light, air, moisture, and contaminants is essential for maintaining their stability and efficacy, making primary packaging a critical component.
“Plastic is largest growing segment on the basis of raw material, in terms of value, during the forecast period.”
The increasing prominence of plastic raw materials in the pharmaceutical packaging market can be attributed to several factors. Firstly, plastics provide a versatile platform for designing and implementing a diverse range of packaging solutions tailored to meet specific pharmaceutical requirements. Additionally, the cost-effectiveness of plastics, both in production and transportation, contributes to overall economic efficiency. The lightweight characteristics of plastic materials facilitate easier handling, resulting in reduced transportation costs and minimized environmental impact. Moreover, plastics boast excellent barrier properties, offering effective protection for pharmaceutical products against external factors such as moisture and contaminants.
Get a Sample Copy of This Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=890
“Oral drug delivery is largest growing segment on the basis of drug delivery, in terms of value, during the forecast period.”
Several factors contribute to the dominance of oral drug delivery in the pharmaceutical packaging market. Firstly, a significant portion of pharmaceutical preparations is intended for oral consumption, making oral drug delivery packaging the largest segment in the market. Secondly, oral drug delivery packaging is cost-effective, offering a practical and economical choice for pharmaceutical companies. Thirdly, the flexibility in designing dosage forms makes oral drug delivery an ideal option for pharmaceutical companies. Lastly, the increasing prevalence of chronic diseases and the growing global demand for pharmaceutical products have fueled the expansion of the oral drug delivery packaging market.
“North America is largest growing segment on the basis of region, in terms of value, during the forecast period.”
North America has the largest market share in the pharmaceutical packaging market in terms of value.
Europe has the second largest market share in the pharmaceutical packaging market in terms of value. With prominent consumers like the US, Canada, and Mexico leading the trend, the region thrives on increased construction activities and is a hub of major packaging manufacturers. The pharmaceutical packaging market in North America is experiencing growth due to rapidly evolving pharmaceutical therapies, new drug innovations, and the increasing demand for smart packaging. In North America, essential market drivers include a heightened demand for diverse drug delivery methods, the integration of additional features in packaging products, and the development of packaging solutions with child-resistant and senior-friendly features.
Pharmaceutical Packaging Companies
Berry Global Group, Inc. (US), Gerresheimer AG (Germany), Amcor Plc (Switzerland), Schott AG (Germany), and AptarGroup, Inc. (US) are some of the established players in the pharmaceutical packaging market. The growing trend of rising consumer awareness for safe and secure packaging solutions is driving the market. These players have adopted various strategies such as mergers & acquisitions, joint ventures, and expansion to strengthen their market position.
Berry Global Group, Inc. is a leader in plastic packaging. It operates through three business segments, namely, engineered materials; health, hygiene & specialties; and consumer packaging. Pharmaceutical devices and packaging are offered under the consumer packaging segment. The company provides non-woven film and lamination for a wide range of medical & pharmaceutical applications and for healthcare packaging needs. It offers storage plastic components such as containers, food service products, closures and over caps, and bottle & prescription containers and tubes. The company serves various industries, such as food, healthcare, shipping & transportation, building & construction, and personal care. It manufactures and supplies its packaging solutions to the US, Canada, Mexico, Belgium, France, Spain, the UK, Italy, Germany, Australia, Brazil, Argentina, Colombia, Malaysia, India, China, and the Netherlands. The company operates more than 300 facilities around the globe and has about 47,000 employees.
Inquire Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=890
Gerresheimer AG is one of the leading companies specializing in medicine packaging, drug delivery devices, and comprehensive solutions for the pharmaceutical industry. The company is primarily dedicated to the production and supply of glass and plastic packaging solutions on a global scale for the pharmaceutical and healthcare sectors. It functions through three key business segments: plastics & devices, primary packaging glass, and advanced technologies. Gerresheimer AG conducts its pharmaceutical packaging operations through the primary packaging glass and plastics & devices segments. With a presence in 16 countries across three continents—Europe, the Americas, and Asia—the company operates 36 manufacturing plants. These locations include Poland, Mexico, Switzerland, Singapore, India, the Czech Republic, Brazil, Belgium, China, France, Denmark, Spain, North Macedonia, and the US. Employing more than 10,000 individuals, the company has a workforce of 4,504 in the plastics & devices segment and 5,333 in the primary packaging glass segment.
Amcor PLC is a leading packaging company for food, beverage, pharmaceutical, medical, home & personal care, and other products. It is primarily involved in the manufacturing and marketing of flexible packaging, rigid containers, and specialty cartons and closures by using raw materials such as polymers, aluminum foils, and fibers. The company operates through two business segments, namely, Amcor flexibles and Amcor Rigid Plastics. Amcor flexibles business produces flexible packaging for food, beverage, pharmaceutical, medical, home, and personal care, and other products, whereas Amcor’s rigid business develops and produces rigid containers and closures for food, beverage, spirits, home and personal care, and healthcare products. Amcor has a wide range of healthcare packaging for oral, dermal, medical devices, hospital packaging, ophthalmic & vision care, pulmonary, intravenous fluid, and injectables. It performs its operations through subsidiaries in the EMEA (Europe, Middle East, and Africa), the Americas, and Asia Pacific. The company operates through 220 production sites in more than 40 countries. It has 78 sales, corporate, other offices, and research sites with more than 44,000 employees. Amcor flexibles operate through 175 plants in 43 countries with more than 40,000 employees and Amcor rigid operates 50 plants in 11 countries with more than 6,000 employees.
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America’s Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the ‘GIVE Growth’ principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
Media ContactCompany Name: MarketsandMarkets™ Research Private Ltd.Contact Person: Mr. Rohan SalgarkarEmail: Send EmailPhone: 18886006441Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445City: FloridaState: FloridaCountry: United StatesWebsite: https://www.marketsandmarkets.com/Market-Reports/pharmaceutical-packaging-market-890.html
